Treatment of WEHI7.2 cells, a mouse thymoma-derived cell line, with dexamethasone, a synthetic glucocorticoid, causes the cells to undergo apoptosis. Previous work has shown that treatment of WEHI7.2 cells with dexamethasone results in a downregulation of antioxidant defense enzymes, suggesting that increased oxidative stress may play a role in glucocorticoid-induced apoptosis. To test whether resistance to oxidative stress causes resistance to dexamethasoneinduced apoptosis, WEHI7.2 cell variants selected for resistance to 50, 100 and 200 mM H 2 O 2 were developed. Resistance to H 2 O 2 is accompanied by increased antioxidant enzyme activity, resistance to other oxidants and a delayed loss of viable cells after dexamethasone treatment. In the 200 mM H 2 O 2 -resistant cell variant the delay in cell loss is correlated with delayed release of cytochrome c from the mitochondria into the cytosol. This suggests that reactive oxygen species play a role in a signaling event during steroidmediated apoptosis in lymphocytes. Cell Death and Differentiation (2001) 8, 953 ± 961.
Introduction
Glucocorticoid-mediated apoptosis plays an important role in lymphoid tissues during maturation of thymocytes and chemotherapy in lymphoid neoplasms (reviewed in 1 ). Although glucocorticoid-induced apoptosis in lymphoid tissues is well documented, the molecular events which cause the cellular commitment to apoptosis after glucocorticoid treatment are not understood.
The biological effects of glucocorticoids are mediated, for the most part, through binding of the ligand to the receptor in the cytosol and translocation of the complex to the nucleus where this complex exerts its effects on transcription. 2 Several groups have found induction or repression of a small, but growing, number of transcripts during glucocorticoid-induced apoptosis in lymphoid tissues. 1,3 ± 6 In WEHI7.2 cells, a mouse thymoma cell line, treatment with the synthetic glucocorticoid, dexamethasone, causes a number of antioxidant defense enzymes to be downregulated at the transcriptional level. 7 Catalase and glutathione peroxidase, which metabolize H 2 O 2 ; superoxide dismutase, which detoxifies O 2 ×7 ; and thioredoxin, a protein which participates in producing reducing equivalents in the cell, are all downregulated at the mRNA level shortly after dexamethasone treatment. 7, 8 Concomitant with the downregulation of the antioxidant defense enzymes is an increase in transcripts for glutathione S-transferase, 7 an enzyme thought to be involved in detoxification of lipid peroxidation products. 9 This suggests that oxidative stress may play a role in dexamethasone-induced thymocyte apoptosis.
Oxidative stress occurs when production or exposure to reactive oxygen species (ROS) outstrips the ability of the cell to remove them. This can occur by an increase in ROS production or a decrease in the ability of the cell to metabolize them. 10 Results from other studies are consistent with a critical role for ROS in dexamethasoneinduced lymphocytes apoptosis: (1) exogenous treatment of thymocytes with chemical antioxidants or antioxidant enzymes protects against dexamethasone-induced apoptosis; 8,11 ± 16 (2) treatment with metal chelators has been shown to inhibit this type of cell death; 11, 17 (3) culture of thymocytes under hypoxic conditions generally affords protection from dexamethasone; 8, 15, 18 and (4) lipid peroxidation, as a measure of oxidative damage, is seen after glucocorticoid treatment in thymocytes 19 and S49.1 lymphocytes. 20 Whether ROS are important as signals in apoptosis or produced only during the execution phase is far from clear (see discussion in 21 ± 23 ). Hyperproduction of ROS in the later (or execution) stages of apoptosis is thought to be caused by the disruption of the mitochondrial respiratory chain after release of cytochrome c into the cytosol. laboratories suggest that ROS are produced sufficiently early after dexamethasone treatment to act as mediators of steroid-induced apoptosis in lymphocytes. 14, 16, 19 If ROS are critical to the mechanism of steroid-induced apoptosis, then bolstering the endogenous cellular antioxidant defense should protect the cells from death in the presence of steroids. By continuous growth of WEHI7.2 cells in the presence of hydrogen peroxide, we have developed several cell variants with altered antioxidant enzyme profiles. These cell variants have provided useful tools to test the importance of endogenous antioxidant defenses in dexamethasone-induced apoptosis and gain insight into the role of ROS in this process.
Results

Cell growth and hydrogen peroxide resistance
Selection for growth in the presence of hydrogen peroxide has resulted in cell populations which exhibit hydrogen peroxide resistance proportional to the selection concentration as shown in Figure 1 To determine whether selection for growth in the presence of H 2 O 2 affected the rate of cell growth we compared the doubling time of the hydrogen peroxideresistant cell variants (H 2 O 2 R) to that of the parental WEHI7.2 cells (Table 1 ). In the absence of H 2 O 2 , cells resistant to 50 mM (50R), 100 mM (100R) and 200 mM (200R) H 2 O 2 showed slightly longer doubling times than the parental cells; however, the differences were not significant. A comparison of the doubling times in the resistant cell variants indicated no significant differences among the cell variants and no correlation between degree of hydrogen peroxide resistance and doubling time.
Antioxidant enzyme profile
Selection for growth in the presence of a drug is often accompanied by alterations in the metabolic pathways for detoxifying the compound. A comparison of antioxidant defense enzyme activities in the H 2 O 2 R cells showed that selection resulted in cell variants with altered antioxidant enzyme profiles (Figure 2 ) . Surprisingly, catalase activity in the 100R cells appeared to be similar or slightly less than that of the parental cells. Two isoforms of glutathione peroxidase that detoxify cytosolic H 2 O 2 have been reported, one that is seleniumdependent and another that is selenium-independent. 30 Activity for each of the two glutathione peroxidase isoforms was undetectable in the parental cells under normal cell culture conditions (low selenium). Similarly, under these conditions, glutathione peroxidase activity was undetectable in the H 2 O 2 R cells. Supplementation of the medium with 100 nM NaSeO 3 was required to result in measurable activity (82 mU/mg protein in the parental cells), suggesting glutathione peroxidase was not a major player in this system. Thioredoxin peroxidases detoxify H 2 O 2 at the expense of reducing equivalents from thioredoxin and ultimately NADPH. 31 We have examined expression of three of the known mammalian thioredoxin peroxidase isoforms, AOE372, 32 NKEFA and NKEFB. 33 No alterations in constitutive mRNA levels were seen when thioredoxin peroxidase expression was normalized to GAPDH (data not shown).
Increases in antioxidant enzymes not directly involved in the detoxification of H 2 O 2 were also seen ( Figure 2 ). Total superoxide dismutase activity was slightly increased in the 50R and 100R cells and significantly elevated in the 200R cells when compared to the WEHI7.2 parental cells. Glutathione S-transferase activity was also increased in the three H 2 O 2 R cell variants.
Resistance to other agents
The elevated superoxide dismutase activity in the H 2 O 2 R cells suggested that these cell variants might be resistant to O 2
×7
. To test this, the relative number of viable cells in parental and H 2 O 2 R cell cultures was compared following incubation in the presence of paraquat (methyl viologen). Paraquat readily enters mammalian cells and is metabolized to produce endogenous superoxide anions. 28 All three hydrogen peroxide-resistant cell variants were significantly more resistant to paraquat when compared to the parental cells, but not significantly different from each other. The EC 50 for paraquat in the parental cells was 46+9 mM and increased to 85+19, 90+20 and 83+18 mM in the 50R, 100R and 200R cell variants, respectively.
To determine whether the H 2 O 2 R cells were more resistant to other agents that are less or not dependent on ROS we compared the relative cell death in response to several agents which are known inducers of apoptosis in WEHI7.2 cells 34 and work by different mechanisms ( Table  2) . Treatment with etoposide, a topoisomerase II inhibitor, 35 which does not cause an increase in ROS in thymocytes 19 caused similar amounts of cell death in all three H 2 O 2 R variants and the parental cells. However, the 200R cells showed less cell death in response to treatment with thapsigargin, an endoplasmic reticulum Ca 2+ -ATPase pump inhibitor, 36 which does cause an ROS increase in thymocytes. 19 The 200R cells also showed less cell death than 50R, 100R or WEHI7.2 cells after treatment with staurosporine, a general kinase inhibitor. 37 Spontaneous cell death in the 200R cell cultures was also significantly decreased when compared to parental cell cultures; however, this does not account for the observed resistance to staurosporine and thapsigargin.
Protection from dexamethasone-induced apoptosis
We next tested whether selection for hydrogen peroxide resistance resulted in cell variants that are protected from dexamethasone-induced apoptosis. After a 48 h treatment with dexamethasone all three H 2 O 2 -resistant variant cell cultures contained significantly more viable cells than the parental cell culture ( Figure 3 ). This indicated that selection for hydrogen peroxide resistance protected against dexamethasone-induced apoptosis; however, the pattern of cell loss differed among the H 2 O 2 R variants. Loss of viable cells in the presence of dexamethasone appeared to be slower in the 50R variant than the parental cells and slowest of all in the 200R cells. In the 100R cells, the major difference was the greater increase in cell number after dexamethasone treatment compared to the parental cells. Morphological assessment of cells at selected timepoints verified that cell loss was due to apoptosis (data not shown). Functional glucocorticoid receptor number was similar in parental and H 2 O 2 R cells, as was the growth of the cells in the presence of vehicle alone (data not shown). 
Bcl-2 status
We examined the Bcl-2 status of the H 2 O 2 R cell variants to determine whether alterations in Bcl-2 could explain the dexamethasone resistance in the H 2 O 2 R cell variants. Bcl-2 protects cells from apoptosis induced by a number of agents, including both dexamethasone and H 2 O 2 , 20, 38, 39 and may play a role in the cellular response to oxidative stress. 20,40 ± 42 No consistent alterations in Bcl-2 protein or pattern of expression that could explain the resistance to dexamethasone was found (Figure 4 ).
Delayed loss of cytochrome c into the cytosol
Two major cellular apoptotic pathways have been elucidated, the death receptor pathway and the mitochondrial pathway. These are activated by different agents and use different activator caspases. 43 Data from caspase knockout mice suggest that dexamethasone induces apoptosis in thymocytes via the mitochondrial pathway. 44 ± 46 In this pathway, an as yet unknown series of events (the signaling phase) results in the release of cytochrome c from the mitochondria into the cytosol (the commitment to die). Released cytochrome c triggers caspase activation resulting in cleavage of cellular targets (execution phase). To determine whether the 200R cells were protected during the signaling phase of apoptosis, we compared the kinetics of cytochrome c release after dexamethasone treatment in the WEHI7.2 parental cells to that in the 200R cells. Twenty-four hours after the addition of dexamethasone, cytochrome c was easily detectable in the cytosol of the WEHI7.2 cells ( Figure 5 ). In the 200R cells, the cytochrome c release was delayed so that only a trace was detectable in the cytosol 24 h post-dexamethasone treatment; however, after 32 h in drug cytosolic cytochrome c was readily detectable. The content of cytochrome c oxidase subunit I, a mitochondrial specific protein, in all of the cytosolic preparations was minimal and similar (data not shown). This indicates that the pattern of cytosolic cytochrome c seen in Figure 5 was not due to contamination of the cytosolic preparation with mitochondria.
Discussion
Selection for resistance to H 2 O 2 bolsters the endogenous antioxidant defense in WEHI7.2 cells and results in cell variants that are protected against dexamethasone-induced apoptosis. The delayed release of cytochrome c into the cytosol in the 200R cells after dexamethasone treatment indicates that the protection occurs prior to the commitment to die. This suggests that ROS are involved in the signaling phase during steroid-mediated apoptosis. This ROS effect is separable from the hyperproduction of ROS identified in the later stages of apoptosis, induced by many agents, because the hyperproduction is thought to be caused by the disruption of the mitochondrial respiratory chain after release of cytochrome c into the cytosol. 14, 24, 25 Late stage ROS hyperproduction does not affect the apoptotic process per se, but may be an important epiphenomenon that affects the removal of apoptotic cells in tissues. 47 The dexamethasone resistance of the H 2 O 2 R cell variants fits well with previous studies indicating that oxidative stress is a component of glucocorticoid-induced apoptosis. Exogenous addition of antioxidant enzymes, antioxidant vitamins or chemical antioxidants protects cells Cell Death and Differentiation
Resistance to dexamethasone-induced apoptosis ME Tome and MM Briehl from steroid-induced apoptosis. 8,11 ± 15,17 Hypoxia also protects WEHI7.2 cells from dexamethasone-induced apoptosis 8 and abrogates steroid-induced killing in immature thymocytes, 15, 18 although, one study found that either very low oxygen or hyperoxia enhances steroidinduced apoptosis in WEHI7.1 cells. 48 Thymocytes are also protected by divalent ion chelators consistent with a role for the interaction of ROS and metals in Fenton-type chemistry during glucocorticoid-mediated apoptosis. 11 A number of studies have shown that decreased concentrations of reduced glutathione accompany steroid-induced apoptosis, 7,12 ± 14,19 suggesting that cellular redox state is perturbed during this process. Increases in lipid peroxidation after glucocorticoid treatment, as a measurement of oxidative damage, are also seen in thymocytes 19 and S49.1 lymphocytes. 20 Our data demonstrates that the development of hydrogen peroxide resistance in the 200R cells delays cytochrome c release supports a role for ROS in mediating a signaling event during steroid-induced lymphocyte apoptosis. One property of a signaling event is that it should occur relatively shortly after drug treatment. Studies aimed at establishing the chronology of apoptotic events support an early role for ROS. When apoptotic thymocyte populations are collected using Percoll gradients 13 or identified by flow cytometry, 16 small increases in ROS can be seen shortly after steroid treatment. The evidence of lipid peroxidation seen by Bustamante et al. 19 also appeared shortly after drug treatment. Work by Kroemer and colleagues has shown that addition of catalase or N-acetylcysteine, an antioxidant and glutathione precursor, to lymphocyte cultures delays the irreversible loss of mito-chondrial transmembrane potential and the hyperproduction of ROS. 14, 49 Signaling cascades in biological systems can be activated after transient exposure to small amounts of signal. Effective signaling concentrations of ROS may be below current detection limits. This could explain the decrease 50 or a lack of change 20 ) . Cells appear to adapt to the same challenge using cell-type specific mechanisms and can show multiple mechanisms of resistance, some of which appear to be concentration-dependent. Alterations in groups of antioxidant enzymes in response to a single type of challenge suggests that coordinate regulation occurs.
Coordinate changes in groups of enzymes during the adaptation to one type of oxidative stress often confer resistance to other agents. The cross-resistance phenomenon can provide clues to the mechanism by which another compound is lethal because it suggests that resistance to both agents requires something in common. The H 2 O 2 R cells here show increased resistance to oxidants, both H 2 O 2 and paraquat, as well as dexamethasone. The 200R cells, with the greatest resistance to H 2 O 2 and dexamethasone, are also resistant to staurosporine and thapsigargin, agents which have been reported to induce oxidative stress, 19, 57 even though this may not be the major pathway by which they induce apoptosis. That the 200R cells and WEHI7.2 cells are equally sensitive to etoposide, which does not stimulate an increase in ROS in thymocytes, 19 suggests that not all apoptotic pathways are altered in these cells. Further support for a role for ROS in glucocorticoid-induced apoptosis comes from the observation that the steroid-resistant WEHI7.2 mutants 34 while transfection of the same cell type with a redox-inactive thioredoxin mutant sensitizes the cells to dexamethasone. 59 Comparison of the cell loss rate in each of the three cell variants described here suggests that increases in catalase activity are most closely correlated with increased protection.
In our model for dexamethasone-induced lymphocyte apoptosis, the downregulation of antioxidant defense enzymes by dexamethasone results in an increase in intracellular ROS because the cells can no longer remove the ROS generated by normal metabolism. The increase in ROS either by itself or due to oxidative damage initiates a signaling cascade that results in the release of cytochrome c from the mitochondria. Binding of cytochrome c to Apaf-1 and procaspase-9 in the apoptosome then initiates activation of the caspases. The simplest explanation for the steroid resistance seen in the H 2 O 2 R cells is that the increased antioxidant defense removes more of the ROS generated by dexamethasone treatment so that the ROS signal is not generated or the ROS damage does not occur. However, there are other potential models. A second possibility is that the ROS increase due to dexamethasone treatment occurs, but the redox status of the cells is altered so a redox-sensitive pathway remains unstimulated and the signal does not propagate. The resistance of the 200R cells to both staurosporine and thapsigargin suggests potential signaling pathways containing protein kinases or Ca 2+ could be involved. Signaling pathways involving each of these components have been implicated in steroid-induced lymphocyte apoptosis.
60 ± 64 A third possibility is that an altered redox state in the H 2 O 2 R cells provides protection for the mitochondria so that, although the signaling cascade is activated, the mitochondria resist cytochrome c release. The H 2 O 2 R cells will provide an excellent tool to test these possibilities.
Materials and Methods
Cell culture
The mouse thymoma-derived WEHI7.2 parental cell line 65 was obtained from Dr. Roger Miesfeld (University of Arizona, Tucson, AZ, USA). Cells were maintained in Dulbecco's Modified Eagle Medium ± low glucose (GIBCO ± BRL Products, Grand Island, NY, USA) supplemented with 10% calf serum (Hyclone Laboratories, Logan, UT, USA) at 378C in a 5% CO 2 humidified environment. Cells were maintained in exponential growth at a density between 0.02 and 2610 6 cells/ml. Prior to each experiment, live cells were separated from the spontaneously apoptotic cells in the culture using FicollPlaque Plus reagents and the manufacturer's procedure for isolation of lymphocytes (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Chemicals and drugs
All chemicals and drugs used in these experiments were obtained from Sigma Chemical Co. (St. Louis, MO, USA) unless otherwise noted.
Selection of hydrogen peroxide-resistant cells
Cells were subcultured and treated with freshly diluted H 2 O 2 resulting in a final concentration of 50 mM H 2 O 2 in the culture medium. Growth was allowed to continue for 3 days, then the cells were counted, subcultured and treated with fresh H 2 O 2 . This routine continued until the doubling time of the cells reached a plateau (approximately 3 weeks). An aliquot containing 5610 5 cells was then transferred to the next highest H 2 O 2 concentration (100 mM) and the same procedure followed. Cells were also maintained in 50 mM H 2 O 2 by subculturing every 3 days in fresh H 2 O 2 -containing medium. After cells were adapted to 100 mM H 2 O 2 (approximately 2.5 weeks), one aliquot was transferred to a new culture and treated with 200 mM H 2 O 2 while another aliquot of cells was used to maintain the 100 mM-resistant population. Cells were adapted to culture in the presence of 200 mM 
Enzyme activity assays
Prior to enzyme activity measurements, cells were washed twice with phosphate-buffered saline (PBS) at 48C. For the measurement of catalase, cells were resuspended in 10 mM Tris-HCl, pH 7.5, 250 mM sucrose, 1 mM EDTA, 0.5 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride and 1% Triton X-100. Samples were incubated for 30 min at 48C and centrifuged at 10 0006g for 15 min at 48C. Activity was measured in the supernatant fractions as the decrease in H 2 O 2 absorbance at 240 nm as described by Beers and Sizer 66 and calculated using an extinction coefficient of 43.6 M 71 cm 71 . Total superoxide dismutase activity was measured using the method of Paoletti et al. 67 Briefly, cells were sonicated (Vibra Cell, Sonics & Materials, Inc., Danbury, CT, USA) in 100 mM triethanolaminediethanolamine buffer, pH 7.4. Activity was measured by the inhibition of superoxide-dependent NADH oxidation using cell lysates and compared to that of purified enzyme. One unit of enzyme is defined as that which causes 50% inhibition. Glutathione S-transferase activity was measured using a 1-chloro-2,4 dinitrobenzene substrate as in Habig et al. 68 Cells were lysed in PBS containing 0.1% Triton X-100 and centrifuged at 10 0006g for 5 min at 48C before the assay. Activity was calculated using an extinction coefficient of 9.6 mM 71 cm 71 . Selenium-dependent glutathione peroxidase was measured by preparing the samples as for catalase activity and assayed using H 2 O 2 as a substrate as described in Zhang et al.
30
Non-selenium dependent glutathione peroxidase activity was measured in the same samples using cumene hydroperoxide as a substrate. 30 Glutathione peroxidase activity was calculated by comparison to the activity of purified protein. All enzyme activities were normalized to cellular protein, measured using the BCA protein assay kit (Pierce, Rockford, IL, USA) according to manufacturer's instructions.
Measurement of sensitivity to drugs
Sensitivity to H 2 O 2 or paraquat (methyl viologen) was determined by subculturing cells in the presence or absence of drug. After incubation for 48 h, an aliquot of the culture was mixed with an equal volume of a 1 mg ml Eosin Y solution and allowed to stand for a few minutes. Cells that excluded dye were scored as viable. For each particular cell variant and treatment, data are expressed as a ratio of the viable cell number in the presence of drug to the viable cell number in the absence of drug6100.
Sensitivity to dexamethasone-induced apoptosis was measured by treating cells with either a final concentration of 1 mM dexamethasone in an ethanol vehicle (final ethanol concentration=0.01%) or an equivalent amount of vehicle alone and periodically scoring viable cells based on dye exclusion as described above. At selected timepoints, an aliquot of cell culture was removed for morphological assessment. Cells were washed twice in PBS and fixed in 3% glutaraldehyde in 100 mM cacodylate, pH 7.2, for 1 h. Subsequently, cells were washed three times in 100 mM cacodylate, pH 7.2, and embedded in epoxy resin. One mm-thick sections from these blocks were stained with toluidine blue for bright field microscopy.
Cell death due to etoposide, staurosporine and thapsigargin was measured by treating cells with 1 mM etoposide for 16 h, 100 nM staurosporine for 24 h, 100 nM thapsigargin for 24 h or dimethyl sulfoxide (DMSO) vehicle alone (final concentration=0.01%) for similar periods. 
Glucocorticoid receptor number measurements
Receptor number was compared by transient transfections of parallel cultures with a vector encoding green fluorescent protein (GFP) (EGFP.C1 Clontech Laboratories, Inc., Palo Alto, CA, USA) or a glucocorticoid response element/GFP reporter plasmid constructed from the same vector (donated by Dr. Roger Miesfeld) using a method similar to Askew et al. 69 Briefly, cells were transfected by electroporation and allowed to recover for 16 h. Cultures of cells transfected with the glucocorticoid responsive GFP were treated with 1 mM dexamethasone for 24 h and assayed for fluorescence by flow cytometry using the LYSIS II analysis program (FACScan, Becton Dickinson, USA). Transfections with the non-glucocorticoid responsive GFP were used to correct for transfection efficiency.
Northern blots
Cells were harvested by centrifugation and the cell pellet frozen dry at 7808C until use. RNA was isolated from the cell pellet using the RNaid kit (Bio 101, Inc., La Jolla, CA, USA) and the manufacturer's suggested protocol except that the cell pellet was sonicated into the lysis buffer at the beginning of the isolation. Fifteen mg RNA per sample was loaded onto a gel, electrophoresed and blotted onto Duralon membranes (Stratagene, La Jolla, CA, USA) according to standard protocols. 70 RNA was attached to the membranes by UV cross-linking (Stratalinker, Stratagene, La Jolla, CA, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA was obtained as previously described by Siemankowski et al. 71 cDNAs for the three human thioredoxin peroxidase isoforms, AOE372, 32 NKEFA and NKEFB, 33 were a kind gift from Margareta Berggren (Dr. Garth Powis' laboratory, University of Arizona, Tucson, AZ, USA). These sequences were obtained by using RT ± PCR to clone them from Jurkat cell mRNA. The resulting cDNAs were inserted into the multiple cloning site of the pBK-CMV vector (Stratagene) and sequenced for confirmation. Target cDNA sequences were excised, purified and 32 P-labeled probes made as previously described. 71 Blots were probed using standard protocols. 70 Transcript levels were quantitated by exposure of the membrane to a phosphorimager screen (Molecular Dynamics, Sunnyvale, CA, USA). GAPDH transcript levels were used to correct for differences in loading and transfer.
Measurement of cytochrome c and Bcl-2
Cell cultures were treated with 1 mM dexamethasone or vehicle as described above and harvested by centrifugation (10006g for 5 min at 48C). Cell pellets were washed with PBS and the cytosolic (S100) and mitochondrial fractions prepared as in Vander Heiden et al. 72 except that cells were resuspended in buffer A without sucrose and allowed to sit for 30 min before the addition of sucrose to make a final concentration of 250 mM. Cells were immediately lysed by douncing, using 20 strokes in a 7 ml glass homogenizer with a glass pestle (Kontes, Vineland, NJ, USA). Proteins from cytosolic and mitochondrial fractions (30 mg of each sample) were separated on a 15% SDS ± PAGE gel 73 and proteins transferred onto PVDF membranes (NEN Research Products, Boston, MA, USA) using a 25 mA current at 48C overnight in blotting buffer. 74 Blots were probed for cytochrome c using 1 mg/ml anti-cytochrome c antibody (PharMingen, San Diego, CA, USA) and cytochrome c oxidase using 1 mg/ml anti-cytochrome oxidase subunit I antibody (Molecular Probes, Eugene, OR, USA) using the manufacturer's protocol accompanying the cytochrome c antibody. Proteins were detected by first incubating with a 1 : 2000 dilution of horseradish peroxidaselinked anti-mouse Ig (Amersham Pharmacia Biotech), then visualizing the product by incubation with chemiluminescence reagents (Renaissance Western Blot Chemiluminescence Reagent Plus, NEN Research Products) as suggested by the manufacturer and exposure to film (X-OMAT Blue, Kodak, Rochester, NY, USA).
For measurement of Bcl-2, samples were prepared as for the catalase enzyme activity assay, then 60 mg protein separated on a 15% SDS ± PAGE gel and transferred to a PVDF membrane as described above. Bcl-2 was detected by incubation of the membrane with a 1 : 1000 dilution of anti-mouse Bcl-2 antibody (Upstate Biotechnology, Lake Placid, NY, USA) using the protocol accompanying the Bcl-2 antibody. After incubation with anti-Bcl-2, the membranes were incubated with horseradish peroxidase-linked anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) at a 1 : 80 000 dilution, treated with chemiluminescence reagents (ECL Western Blotting Analysis System, Amersham Pharmacia Biotech) and exposed to film.
Statistics
Means were compared using ANOVA or a Student's t-test assuming unequal variances. Significant difference was set at P50.05.
